Nucleostemin is a pivotal protein predominantly localized in the nucleolus, known for its significant role in the regulation of stem cell proliferation and the maintenance of cellular senescence. This protein is highly expressed in embryonic stem cells, various cancer cells, and adult stem cells, where it functions to sustain the proliferative capacity and prevent premature cellular aging. Nucleostemin works by regulating the cell cycle and maintaining the undifferentiated state of stem cells, playing a crucial role in stem cell biology and tumorigenesis. Its activity is essential for the renewal and differentiation processes in stem cells, indicating its critical role in developmental biology and regenerative medicine. The regulation of nucleostemin is intricately linked to its localization within the nucleolus, where it interacts with other molecular components to influence ribosomal biogenesis, cell cycle progression, and apoptosis. Its ability to shuttle between the nucleolus and nucleoplasm allows it to respond dynamically to cellular needs, mediating critical processes that underpin cellular growth and proliferation.
The activation of nucleostemin is governed by a complex network of signaling pathways and molecular interactions that reflect the cellular environment and the specific demands of cell growth and maintenance. This includes its regulation by phosphorylation, which modulates its stability and interaction with other proteins, and by binding to GTP, which is essential for its function as a GTP-binding protein. The activation mechanisms also involve the response to cellular stress and DNA damage, where nucleostemin is implicated in the cellular recovery processes. Additionally, the protein's expression levels are controlled by transcriptional and post-transcriptional mechanisms, ensuring that its activity is finely tuned according to the phase of the cell cycle and the proliferative state of the cell. Understanding the activation and regulation of nucleostemin offers significant insights into the fundamental processes of cell proliferation, aging, and the maintenance of stem cell properties.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 disrupts the interaction between nucleostemin and p53, preventing nucleostemin-mediated inhibition of p53. By blocking this interaction, Nutlin-3 indirectly promotes the activation of p53, leading to downstream effects on cell cycle regulation and apoptosis. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
PKF115-584 (Calphostin C) is an inhibitor of nucleostemin that disrupts its function in ribosome biogenesis. By targeting nucleostemin, PKF115-584 can indirectly influence cellular processes associated with nucleolar function and potentially impact cell proliferation. | ||||||
NSC348884 | 81624-55-7 | sc-301483 sc-301483A | 5 mg 25 mg | $125.00 $480.00 | 2 | |
NSC348884 is a compound that inhibits nucleostemin and has been associated with effects on cell cycle regulation. Its impact on nucleostemin suggests a potential role in influencing cellular processes related to nucleolar function and proliferation. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone is an anthracenedione derivative that has been reported to modulate nucleostemin expression. Its potential impact on nucleostemin suggests a role in influencing cellular processes associated with nucleolar function and proliferation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D is an antibiotic that affects nucleostemin by interfering with RNA synthesis. Its impact on nucleostemin suggests a potential role in influencing cellular processes related to nucleolar function and proliferation. | ||||||
Oridonin, R. rubescens | 28957-04-2 | sc-202751 | 5 mg | $77.00 | ||
Oridonin is a diterpenoid compound that has been reported to affect nucleostemin expression. Its potential impact on nucleostemin suggests a role in influencing cellular processes associated with nucleolar function and proliferation. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin is an anthracycline antibiotic with reported effects on nucleostemin expression. Its potential impact on nucleostemin suggests a role in influencing cellular processes associated with nucleolar function and proliferation. | ||||||